Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > This is a trading stock.

<< Previous

Bullboard Posts

Next >>

Post by Conquistador1on Jan 11, 2024 12:44pm

612 Views

Post# 35821729

This is a trading stock.

I just bought some stock. I can see 20 cents of downside but 80 cents on the upside.
I've bought and sold the stock on quite a few occasions.
I ignore the hype of a potential mega deal. I'm not impressed by the over-priced management team.
ONC has enough cash to survive the year. It is a trade.

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs